Immunology-focused biotech Santa Ana Bio announced Thursday that it has launched with a $168 million war chest to advance two of its programs into the clinic next year designed to treat inflammatory diseases.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,